COVID-19 vaccines to enter final phase trial today" width="740" />
Speaking about vaccines, Dr Paul said, while one vaccine was in the stage of phase-3 trials, the other two were also progressing well and were in the phase 1-2 of clinical trials.
“We have reviewed all these vaccine candidates. These are progressing well and their developments are taking place in a reassuring manner,” he said. “The outline of vaccine administration and supply chain is ready. As and when required, detailed and micro-level planning for vaccine administration based on a scientific approach according to the characteristics of the vaccine will be adopted,” he added.
He said two doses of a vaccine may have to be taken, and accordingly the plan will be prepared.
Stating that discussions were going on with the vaccine manufacturers, Dr Paul further stated, the Government held discussions with vaccine manufacturers to know about the facilitations they are expecting from the Government. To a reporter’s query, he replied, “We requested the vaccine manufacturers to indicate what possible prices could be. Pricing is very complex as some of these vaccines are at an early stage. We have some insights into what the price range could be, but this is an information that will be refined as we move along.”
Individual vaccine manufacturers have been requested to provide more clear-cut data on their individual production capacities and how their capacities would pan out with time, encouraging them very actively to ramp up capacity with facilitations.
“This is a dialogue in motion,” he said, noting that India had huge potential and capacity in vaccine manufacturing.
Dr Paul said the vaccine, which is in the first and second phase, and their results will be available in one to two weeks and the vaccine which has reached the third stage, it will take longer to get the results, an official release here said. (UNI)